TRAF1 and asthma: Furthermore, hUCMSC-EVs ameliorated severe steroid-resistant asthma (SSRA) by modulating macrophage polarization via the TRAF1/NF-κB/PI3K/AKT axis [15], highlighting their broad anti-inflammatory potential.